GL1X · GenesisL1 explorer

MolNFT v1 · #147402 · protein

Halk in complex with compound 9 (6-(((1S)-1-(5-fluoropyridin-2-yl) ETHYL)AMINO)-1-(3-methyl-1H-pyrazol-5-yl)-1H-PYRROLO[2,3-B]PYRIDIN-3- YL)(MORPHOLIN-4-YL)METHANONE

6EBW · ALK tyrosine kinase receptor: “Halk in complex with compound 9 (6-(((1S)-1-(5-fluoropyridin-2-yl)…”. X-ray diffraction, 1 ligand (J3Y), 1 pocket (best druggability 0.61). MolNFT v1 #147402 on GenesisL1: 3D structure, binding sites…

PDB
6EBW
Type
protein
Length
277 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
ALK tyrosine kinase receptor
EC
2.7.10.1
UniProt
Q9UM73
Ligands
J3Y
Pockets
1 · best druggability 0.61

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AALK tyrosine kinase receptor (EC 2.7.10.1)protein27742% helix, 15% strandQ9UM73

Ligands and binding sites

  • J3Y · [6-{[(1S)-1-(5-fluoropyridin-2-yl)ethyl]amino}-1-(5-methyl-1H-pyrazol-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl](morpholin-4-yl)methanone · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13190.610.7941J3Y

Compared structures

  • 6EBW · hALK in complex with compound 9 (6-(((1S)-1-(5-Fluoropyridin-2-yl)ethyl)amino)-1-(3-methyl… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UM73 · AlphaFold monomer V2.0 prediction for ALK tyrosine kinase receptor (Q9UM73) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.